Compare ASML Holding NV (ASML) vs TransMedics Group Inc (TMDX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ASML Holding NV vs TransMedics Group Inc — how do they compare? ASML Holding NV trades at $1,828.14 (market cap $689.17B), while TransMedics Group Inc trades at $89.19 (market cap $3.10B). The key difference: ASML Holding NV is far larger — about 222.3× TransMedics Group Inc's market cap, and ASML Holding NV pays a 0.5% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| ASML | TMDX | |
|---|---|---|
Market Cap | $689.17B | $3.10B |
Sector | Technology | Technology |
52-Week High | $1.99K | $150.42 |
52-Week Low | $725.85 | $61.99 |
Enterprise Value | $682.70B | $3.49B |
Dividend Yield | 0.5% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ASML Holding NV
Founded in 1984 and based in the Netherlands, ASML is the leader in photolithography systems used in the manufacturing of semiconductors. Photolithography is the process in which a light source is used to expose circuit patterns from a photomask onto a semiconductor wafer. The latest technological advances in this segment allow chipmakers to continually increase the number of transistors on the same area of silicon, with lithography historically representing a meaningful portion of the cost of making cutting-edge chips. Chipmakers require next-generation EUV lithography tools from ASML to continue past the 5-nanometer process node. ASML's products are used at every major semiconductor manufacturer, including Intel, Samsung, and TSMC.
Read more on ASML →About TransMedics Group Inc
TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →
